GOED Publications

The following is a list of peer-reviewed publications co-authored by a GOED employee(s) or commissioned by GOED.

  • Dicklin MR, Anthony JC, Winters BL, Maki KC. ω-3 Polyunsaturated Fatty Acid Status Testing in Humans: A Narrative Review of Commercially Available Options. J Nutr. Epub ahead of print on 22 March 2024. [Link]
  • Laukkanen JA, Bernasconi AA, Lavie CJ. Bringing the Potential Benefits of Omega-3 to a Higher Level. Mayo Clin Proc. 2024; 99:520-523. [Link]
  • Roke, K, Natker E. EPA and DHA Omega-3s and Diabetes: What the Science Says. ADCES in Practice. 2023; 11:20-24. [Link]
  • Andriambelo B, Stiffel M, Roke K, Plourde M. New perspectives on randomized controlled trials with omega-3 fatty acid supplements and cognition: a scoping review. Ageing Res Rev. 2023; 85:101835. [Link]
  • Bernasconi AA, Wilkin AM, Roke K, Ismail A. Development of a novel database to review and assess the clinical effects of EPA and DHA omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2022; 183:102458 [Link]
  • Lavie CJ, Bernasconi A. Impressive results with EPA, but EPA/DHA combinations also reduce cardiovascular outcomes. Prog Cardiovasc Dis. 2021; 69:110-112.  [Link]
  • Rice HB, Bannenberg G. Letter to the editor regarding “Omega-3 fats in pregnancy: could a targeted approach lead to better metabolic health for children?” Nutr Rev. 2022; 80:136-137. [Link]
  • Bernasconi AA, Lavie CJ, Milani RV, Laukkanen JA. Omega-3 Benefits Remain Strong Post-STRENGTH. Mayo Clin Proc. 2021; 96 :1371-1372. [Link]
  • Lavie CJ, Milani RV, Laukkanen JA, Bernasconi AA. In Reply-Impact of a High- Shrimp Diet on Cardiovascular Risk: An NHANES Analysis. Mayo Clin Proc. 2021; 96: 508. [Link]
  • Phung A, Bannenberg G, Vigor C, Reversat G, Oger C, Roumain M, Galano JM, Durand T, Muccioli G, Ismail A, Wang S. Chemical Compositional Changes in Over-Oxidized Fish Oils. Foods. 2020; 10: 1501. [Link].
  • Bannenberg G, Rice HB. Letter to the Editor Regarding Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review. Adv Ther. 2020; 37: 4043-4045. [Link]
  • Bernasconi A, Wiest M, Lavie C, Milani R, Laukkanen J. Effect of Omega-3 Dosage on Cardiovascular Outcomes. Mayo Clin Proc. 2021; 96; 304-313. [Link]
  • Bannenberg G, Rice HR, Bernasconi A, Ferrari A, Mallon C, Navarrete L, Hughes R, Igarashi J, Persons K, Latynski L, Phung A, Wang S, Ismail A. Ingredient label claim compliance and oxidative quality of EPA/DHA omega-3 retail products in the U.S., Journal of Food Composition and Analysis. 2020; 88:E103435. [Link]
  • Maki KC, Dicklin MR. Omega-3 Fatty Acid Supplementation and Cardiovascular Disease Risk: Glass Half Full or Time to Nail the Coffin Shut? Nutrients. 2018; 10:E864. [Link]
  • De Boer AA, Ismail A, Marshall K, Bannenberg G, Yan KL, Rowe WJ. Examination of marine and vegetable oil oxidation data from a multi-year, third-party database. Food Chem. 2018; 254:249-55. [Link]
  • Maki KC, Palacios OM, Bell M, Toth PP. Use of supplemental long-chain omega-3 fatty acids and risk for cardiac death: An updated meta-analysis and review of research gaps. J Clin Lipidol. 2017; 11:1152-60. [Link]
  • Bannenberg G, Mallon C, Edwards H, Yeadon D, Yan K, Johnson H, Ismail A. Omega-3 Long-Chain Polyunsaturated Fatty Acid Content and Oxidation State of Fish Oil Supplements in New Zealand. Sci Rep. 2017; 7:1488. [Link]
  • Rice HB, Bannenberg G, Harwood M, Ismail A. Determining the potential effects of oxidized fish oils in pregnant women requires a more systematic approach. Am J Physiol Regul Integr Comp Physiol. 2017; 312:R263. [Link]
  • Alexander DD, Miller PE, Van Elswyk ME, Kuratko CN, Bylsma LC. A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids and Coronary Heart Disease Risk. Mayo Clin Proc. 2017; 92:15-29. [Link]
  • Rice HB, Ismail A (2016). Fish Oils in Human Nutrition: History and Current Status In Raatz SK and Bibus DM (eds) Fish and Fish Oil in Health and Disease Prevention. Academic Press, Inc. [Link]
  • Ismail A, Bannenberg G, Rice HB, Schutt E, MacKay D. Oxidation in EPA‐ and DHA‐rich oils: an overview. Lipid Technol. 2016; 28:55-9. [Link]
  • Lupton JR, Blumberg JB, L'Abbe M, LeDoux M, Rice HB, von Schacky C, Yaktine A, Griffiths JC. Nutrient reference value: non-communicable disease endpoints--a conference report. Eur J Nutr. 2016; 55 Suppl 1:S1-10. [Link]
  • Rice HB, Bernasconi A, Maki KC, Harris WS, von Schacky C, Calder PC. Conducting omega-3 clinical trials with cardiovascular outcomes: Proceedings of a workshop held at ISSFAL 2014. Prostaglandins Leukot Essent Fatty Acids. 2016; 107:30-42. [Link]
  • Alexander DD, Bassett JK, Weed DL, Barrett EC, Watson H, Harris W. Meta-Analysis of Long-Chain Omega-3 Polyunsaturated Fatty Acids (LCω-3PUFA) and Prostate Cancer. Nutr Cancer. 2015; 67:543-54. [Link]
  • Ismail A, Rice HB. Considerations for incorporating eicosapentaenoic and docosahexaenoic omega-3 fatty acids into the military food supply chain. Mil Med. 2014; 179 Suppl 11:157-61. [Link]
  • Miller PE, Van Elswyk M, Alexander DD. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials. Am J Hypertens. 2014; 27:885-96. [Link]
  • Biesalski HK, Erdman JW Jr, Hathcock J, Ellwood K, Beatty S, Johnson E, Marchioli R, Lauritzen L, Rice HB, Shao A, Griffiths JC. Nutrient reference values for bioactives: new approaches needed? A conference report. Eur J Nutr. 2013; 52 Suppl 1:1-9. [Link]
  • Musa-Veloso K, Binns MA, Kocenas A, Chung C, Rice H, Oppedal-Olsen H, Lloyd H, Lemke S. Impact of low v. moderate intakes of long-chain n-3 fatty acids on risk of coronary heart disease. Br J Nutr. 2011; 106:1129-41. [Link]
  • Ismail A. Marine lipids overview: markets, regulation, and the value chain. OCL. 2010; 17:205-8. [Link]
  • Musa-Veloso K, Binns MA, Kocenas AC, Poon T, Elliot JA, Rice H, Oppedal-Olsen H, Lloyd H, Lemke S. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid dose-dependently reduce fasting serum triglycerides. Nutr Rev. 2010; 68:155-67. [Link]